Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure
Launched by ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST · Jan 29, 2009
Trial Information
Current as of June 12, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Randomised control trials of beta-blocker versus control in patients with documented heart failure
- • Unconfounded trials only (in which one treatment group differed from another only by the beta-blocker therapy of interest)
- • Randomization process precluded prior knowledge of the next treatment (for example trials in which treatment allocation was alternate or based on odd or even dates would not be included)
- Exclusion Criteria:
- • Trial sample size of less than 300 patients
About Royal Brompton & Harefield Nhs Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust is a leading specialist healthcare provider in the United Kingdom, renowned for its expertise in cardiothoracic medicine and respiratory care. Committed to advancing clinical research and improving patient outcomes, the Trust conducts a diverse range of clinical trials aimed at exploring innovative treatments and therapies. With a multidisciplinary team of clinicians and researchers, the Foundation Trust fosters a collaborative environment that prioritizes patient safety and ethical standards, contributing significantly to the global body of medical knowledge and enhancing the quality of care for patients with complex health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Oxford, , United Kingdom
Patients applied
Trial Officials
Marcus Flather
Study Chair
Royal Brompton Hospital, London
Luis Manzano
Study Chair
Universidad de Alcala, Madrid
Dipak Kotecha
Study Chair
Royal Brompton Hospital, London
Henry Krum
Study Chair
Monash University, Melbourne
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials